Obido, Al-nadjer .

HRN: 27-43-22  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/05/2026
04/11/2026
IV
260mg
Q6
PCAP C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines